Titan Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, sales was INR 768.3 million compared to INR 834.47 million a year ago. Revenue was INR 780.03 million compared to INR 838.47 million a year ago. Net income was INR 166.31 million compared to INR 151.16 million a year ago. Basic earnings per share from continuing operations was INR 20.13 compared to INR 18.29 a year ago. Diluted earnings per share from continuing operations was INR 20.13 compared to INR 18.29 a year ago.